id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0378-0061,FDA,FDA-2012-N-0378,"Physical Medicine Devices; Reclassification of Shortwave
Diathermy for All Other Uses, Henceforth To Be Known as
Nonthermal Shortwave Therapy",Rule,Final Rule,2015-10-13T04:00:00Z,2015,10,2015-10-13T04:00:00Z,,2015-10-13T14:10:53Z,2015-25923,0,0,0900006481cc4307
FDA-2012-N-0378-0059,FDA,FDA-2012-N-0378,Response Letter from FDA CDRH to Leroy Leslie Hamilton re FDA-2012-N-0378-0008,Other,Letter(s),2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,,2014-11-25T01:06:08Z,,0,0,090000648194393f
FDA-2012-N-0378-0053,FDA,FDA-2012-N-0378,"Letter from FDA CDRH to MEDIcept, Inc.",Other,Letter(s),2014-06-02T04:00:00Z,2014,6,2014-06-02T04:00:00Z,,2014-06-02T19:07:04Z,,0,0,090000648172427e
FDA-2012-N-0378-0052,FDA,FDA-2012-N-0378,Letter from FDA CDRH to BioElectronics Corporation,Other,Letter(s),2014-06-02T04:00:00Z,2014,6,2014-06-02T04:00:00Z,,2014-06-02T19:01:05Z,,0,0,090000648172427a
FDA-2012-N-0378-0054,FDA,FDA-2012-N-0378,Letter from FDA CDRH to Diapulse Corporation of America,Other,Letter(s),2014-06-02T04:00:00Z,2014,6,2014-06-02T04:00:00Z,,2014-06-02T19:29:50Z,,0,0,09000064817242ef
FDA-2012-N-0378-0050,FDA,FDA-2012-N-0378,Supplement from BioElectronics Corporation,Other,Supplement (SUP),2014-04-17T04:00:00Z,2014,4,2014-04-17T04:00:00Z,,2014-04-17T16:49:46Z,,0,0,090000648169e0b8
FDA-2012-N-0378-0048,FDA,FDA-2012-N-0378,Physical Medicine Devices: Withdrawal of Proposed Effective Date of Requirement for Premarket Approval for Shortwave Diathermy for All Other Uses,Proposed Rule,Withdrawal,2014-02-20T05:00:00Z,2014,2,2014-02-20T05:00:00Z,,2014-02-24T16:31:38Z,2014-03593,0,0,09000064815906a1
FDA-2012-N-0378-0049,FDA,FDA-2012-N-0378,"Physical Medicine Devices; Reclassification and Renaming of
Shortwave Diathermy for All Other Uses",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2014-02-20T05:00:00Z,2014,2,2014-02-20T05:00:00Z,2014-05-22T03:59:59Z,2015-06-12T01:30:53Z,2014-03594,0,0,0900006481590553
FDA-2012-N-0378-0043,FDA,FDA-2012-N-0378,Acknowledgement Letter to Regensis Biomedical,Other,Acknowledgement Letter/Receipt,2012-10-19T04:00:00Z,2012,10,2012-10-19T04:00:00Z,,2012-10-19T13:23:55Z,,0,0,09000064810befd4
FDA-2012-N-0378-0042,FDA,FDA-2012-N-0378,Regenesis Biomedical Inc - Change in Classification Petition,Other,Change in Classification Petition,2012-10-19T04:00:00Z,2012,10,2012-10-19T04:00:00Z,,2012-10-23T18:23:42Z,,0,0,09000064810b201a
FDA-2012-N-0378-0008,FDA,FDA-2012-N-0378,Leroy Leslie Hamilton (re Request to FDA/CDRH to Consider Special Circumstances) Petition for Reclassification,Other,Petition(s),2012-09-13T04:00:00Z,2012,9,2012-07-06T04:00:00Z,2012-10-05T03:59:59Z,2014-11-25T01:06:49Z,,0,0,09000064810b5414
FDA-2012-N-0378-0009,FDA,FDA-2012-N-0378,"Acknowledgement Letter to MEDIcept, Inc.",Other,Acknowledgement Letter/Receipt,2012-09-13T04:00:00Z,2012,9,2012-09-13T04:00:00Z,,2012-09-13T21:27:23Z,,0,0,09000064810bf85a
FDA-2012-N-0378-0007,FDA,FDA-2012-N-0378,"MEDIcept, Inc - Change in Classification Petition",Other,Change in Classification Petition,2012-08-16T04:00:00Z,2012,8,2012-08-16T04:00:00Z,,2012-10-18T16:48:51Z,,0,0,09000064810aba3b
FDA-2012-N-0378-0004,FDA,FDA-2012-N-0378,Acknowledgement Letter to BioElectronics Corporation,Other,Acknowledgement Letter/Receipt,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-08-14T22:53:34Z,,0,0,09000064810be89b
FDA-2012-N-0378-0005,FDA,FDA-2012-N-0378,Diapulse Corporation of America - Change in Classification Petition,Other,Change in Classification Petition,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-10-18T16:47:58Z,,0,0,09000064810b4a4e
FDA-2012-N-0378-0003,FDA,FDA-2012-N-0378,BioElectronics Corporation - Change in Classification Petition,Other,Change in Classification Petition,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-10-19T02:02:08Z,,0,0,09000064810b205e
FDA-2012-N-0378-0006,FDA,FDA-2012-N-0378,Acknowledgement Letter to Diapulse Corporation of America,Other,Acknowledgement Letter/Receipt,2012-08-14T04:00:00Z,2012,8,2012-08-14T04:00:00Z,,2012-08-14T22:56:15Z,,0,0,09000064810bf856
FDA-2012-N-0378-0001,FDA,FDA-2012-N-0378,Effective Date of Requirement for Premarket Approval for Shortwave Diathermy for All Other Uses,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-07-06T04:00:00Z,2012,7,2012-07-06T04:00:00Z,2012-10-05T03:59:59Z,2014-11-30T01:49:58Z,2012-16487,0,0,090000648107d286